pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3179-1 |
Genomic Coordinates | chr16: 14901508 - 14901591 |
Description | Homo sapiens miR-3179-1 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-2 |
Genomic Coordinates | chr16: 16300159 - 16300242 |
Description | Homo sapiens miR-3179-2 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-3 |
Genomic Coordinates | chr16: 18411894 - 18411977 |
Description | Homo sapiens miR-3179-3 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-4 |
Genomic Coordinates | chr16: 18494493 - 18494576 |
Description | Homo sapiens miR-3179-4 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3179 | |||||||||||||||
Sequence | 52| AGAAGGGGUGAAAUUUAAACGU |73 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KCTD12 | ||||||||||||||||||||
Synonyms | C13orf2, PFET1, PFETIN | ||||||||||||||||||||
Description | potassium channel tetramerization domain containing 12 | ||||||||||||||||||||
Transcript | NM_138444 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KCTD12 | |||||||||||||||||||||
3'UTR of KCTD12 (miRNA target sites are highlighted) |
>KCTD12|NM_138444|3'UTR 1 GCTCCCCAGACCCCCTCGCCACTCCAGCGCCCAGTCCTTCTCCTGCCCGAGAGATGATTACAGAGCCTCTTGTCCCACCT 81 TTGTCCCCTGGCTGCTGCCCTCCCATTCTCCCCCTCCAGTAGTAGCTGGGTGAGACCTGTCCGCCCACCTTCCCTCCACT 161 ACAGAACCTGCAGCCGCAAATCCTCTGGGCTGCTTCGTCTTCTTTGGACCTCCTGAACCGAGAGAACCCAGAGGAACCCC 241 CACCCCACCCCCACCTACCACTCCATGCTTTCTCTACTCCCTGCCTCAAACCACCCCTCCCCCAGATGGTACTTCAGTTT 321 GGATCTATTGGGGGAGTGTGGCCACAGACCGGGGGATGATTGAATTGTTCAGAACCTGATTGGACCGTGTCCAATGTGCG 401 GAAGATTTCCTTGAAATCTTCTCAAGCTCTTATGACTCACTGGGGGTTTAAGAGATCAGGATTGGTTCCACTGTCTGGGG 481 TTAGTGTTTTACAAGGTCATTACACAGTCTTTTTGACCTCTTTTGAAGGTAGAGTTTTAGAAGGCTGGATGGAAGATTCT 561 GAGCCTGGAATTAGGACCCCATGGAGGCAGTTCAGTAACTAAACTAATAAAGTTTTGAAAAGTTACACGTAAAGTAGAAG 641 AATCTAGTGCGTGGGACAGTAAAGGATCCTTTCTCGTACAGAATAAAAGGTCTCAGCCTGTAGCTTAAACTTATAGAAAG 721 TGATCCGCCTGCCTGCAGAGGCGCCCTTTTCAGCTGCTGCTCGCCAGAAGCCCTTGATTCCACTGGTTGACATGGCAGCA 801 GTTACTGGCAAGAGGGAGAAAGGACGCTGCCGCCTAAGAGTGCAAGGCTGCTCAGGTCTCCAAGCGCCGTAGGAGGTCAC 881 CTGGCAGTGACTGTAGGGAGCTGGGTCATAGTGCACGTCGTGGGTATTAGGAAAGCCTGTATTCTTTCAATGAATGTCAG 961 TAGGACCTTCCTTTAGCTGTAAGACTTGGTGGGCGGGGTGGGGTGGGGAGGGAGGAAAGGGTAGGAAGGGTGGGAAGGGA 1041 GAAGCAGACATAGTCATTTATGATTTGAAAGTTGGAAGTTTGTACCATCTGTTTGAGTATATGCACATTTAAAAAATATC 1121 ATATAGTAAATGCAAACATGCCAAGTATTTTATAAAGATTAATAACAGACCTACTCTTACCTGGCAGTTTACTTAACTTA 1201 CTGTTTTGAGTCCTAAACTTAGAGTTGTTAATGCTTATATATAATCTAACCAAAGAGTTACCCAGTAGGGTTTTAGTTTT 1281 TGAACTTTTATTTTCTTGTTGATTATAAATCCTGATTTTGGAATCTATTGCGCAAAAGAAGTTTCATTTTGGTTACTTAG 1361 ACCTAAGATCACTTATTAAAAATCCTTATTTTCTCCAAGCCCAGCAAACGTTGACTTCTGGGCAAACCTGAAAACCTGAA 1441 AATGCCACTTTCATGCAGTTTGTTTGAAGTTAAGTGGAATCCTTTCAAATGACGAGCTGCAGAGAACTCAGCACCAAGGG 1521 CTGCCTATCTGTAGATAGCTGTAAAATGGAATATTTTTAAATGAAGGCAAATAAGTACTTAAAAGTGAGCTGAGCAATAA 1601 AATGGTCCAATAATAGGTAAATGCAACAGAAACAGAAGGAGACCTGGTTGCCTTATGCCTTTACTCTTACATGGAATAAA 1681 TTCCCAATGCATATCCTATGTAAACCATAAGTGAAGGGAAATAAACCTCGTCATGCTCCATGCTGTGAGGTGTCCTTTGG 1761 ATATTCTGTGATGACAGAGAAGCCTATTTTGTTTTGTTTTCAGCATCTTTCTCTGATGTACGTTTTTAAGGATTTTGTAA 1841 GAGCTGTTTTCAGTGTTTAAATTAGTGCTATTTTTCCTTGTTTTTAAAAATGAATCTCGTACTGTATCTTACTATGTCCA 1921 TACAGATGTTACAAATCGACAGTTTTATTCTTAGACTCATGTGATCCAAGCTGTATATACCATATATAAACATTTTACAT 2001 GAATCATTTAGTTTTTTAATTCATTTACTAATGCTATAAAATTTCCTATATTACCCCAGTAATTTGCATCAGCTGGTTTA 2081 TATACTAAAGCAACATGTTTTGATGAGTTTCTTACATCCTTATCGAGGAATTGGGTTAGGAAAAAATACATAATTGTAAA 2161 ACTGAGTTTGCTGTATTATACTTTTTTTCTTGAGTATTAGTTGTATTACTAATCATATGTTGATTAACTGTCTACTTAAA 2241 GTCAAGGTACCTGTATTTTTAATCCACTAATTTTTTTTTAGTTGGGAAATAGATTTCAGGTCTTTTATTAGACTAACATT 2321 TTTTGAGAAGTAAAATTGACTTCATATACAAAGCCTGTAATTTTAGGCGAAATGGAAGCAGAAATCTAGGAAGTTGTGCT 2401 TGCTTGTATGTTGAGTTTGGTCTCAGACTAAGTAATGCATCAGAATTCATCTGTTTGAAGCCTGAAATAATTTAGGACTC 2481 TGATTCACTGACCAAAAGTCAGTGTTGCAGAGATTTCTCTACCCCGTATGGTATTTTGTTAGATTGTTCAACAGGAAGCA 2561 CATGATTGAGAACATCTTGGGACAGACCAAAACCACTGACAGATGGCAAGGCTCGGCGATTCTGATTTCCCTTCTCAAAT 2641 CTGCTCAACTCCAAGAGTCTTGAGAAACTGCTAAAATTTTGCCTCTGTCACTCAAGTCTTACAAATGTTATCTTGTAAAC 2721 CTTTGAGGTGAACTATTCCACTGTCTTGTACATAGGCATCTTATTCACTGCACCCTGTCACACCCAGCACCCCCCGCCCC 2801 GCACATTATTTGAAAGACTGGGAATTTAATGGTTAGGGACAGTAAATCTACTTCTTTTTCCAGGGACGACTGTCCCCTCT 2881 AAAGTTAAAGTCAATACAAGAAAACTGTCTATTTTTAGCCTAAAGTAAAGGCTGTGAAGAAAATTCATTTTACATTGGGT 2961 AGACAGTAAAAAACAAGTAAAATAACTTGACATGAGCACCTTTAGATCCCTTCCCCTCCATGGGCTTTGGGCCACAGAAT 3041 GAACCTTTGAGGCCTGTAAAGTGGATTGTAATTTCCTATAAGCTGTAATAGTGGAGGTATTGTGGGTTCATTTGAGTAAG 3121 CCCTCCAAAGATACCATTCAAATAACCTGGGAGAATGTCATAAATTATTCAGATAATTAACACTGCATGAATCTGATTCA 3201 GAGGCATGCATTTACATATGTTGCCCTAATTACCATTTGATGATCATAAATACAAGTGAATGACATTGGACTTTTAGTAA 3281 CAAACTTAATTTTTAAAAAGGTGTAGACAATGGTGGTTAAAAAAAAAAAAAAAACAGGTACCAGGTTCTGTGTGTTTGCA 3361 CCAAGTAATTGACATGTTTTTTAATACATGTGGACCATGAACAGTATTCATTCTACTTTTTCAAATGATATGCTGTAGAA 3441 AATATTCCTTGAAGATGTGAGATTTAAAAATTTTTCCCTTTCAATGTTGTTATGTATTCTACTGGTTTTTGATTGATAGC 3521 ACAGTGATAAATCATAATACTAGACAAAATTGTCTTCTCTTTCAAACCAGAGCCATATATATGTCTGTATATATGGGACC 3601 TACTGCTTCTCTGAGGAAATGCATAATCTGTTAATATCAGACAAAATGAGCAATTGGCAGTGCTCATAATATATTCCAAT 3681 TTTTATTGGAATTTTCGATGGAATGTTATTTCAATAAAGCCATGTAAGGTGAAACTTTGATAACTTTTTACTCTTCAAGT 3761 TAGGGTAAATTCTGATCCAATATTCAATTCATTTGTGTACTCCCACATGCAAAATGCTAAATTACAATGCAGACATTAAG 3841 AAAAAGTATTGACTGGAGGGGTTGAATTCCTTGAGAATTTATTTTATAGTCTAAATCACAAATACTTTACTCAATTTAGT 3921 TTTTAAAATAGTAAACTGAATATTTTTGTTGTAAGCCTATCAGAGTCAATCCTTCGTTTGGAATTGTTTTCCTGTTTTTC 4001 CTTACTATAAATCATTTAAAAACTGAATTCATTTTCTTAGATGGCATAAGTCTGTCTCTTGAGAAATAAGTAAAATACTC 4081 CTATTTTCAGTATCTGTAGCACCTGAAATAGGTCTTTGTATAGCCAGAAACAAGTTATGTTGAAGTTAGCTTTTCTTTGT 4161 CAACAGTTTTGGACAATAAAAATCTGAAAGTATTAACACTTGATTTTCTACTGGGGCCCTTCAAACTTGGTTGGAAGAAA 4241 TTCAACCAGAATATCTACATTAGAGTATAATCATGTGTGGTAGGAAGATGGACTAGTTAATCAAGATTTGTTGTCACTTA 4321 AATTTTTTGTGATTTTTTTCCAAGCCAGTTTTTTTAAATTCTAAATGTGTTTTGAGGTATGGGTACATTAATTGTAATGT 4401 AAACTATTATACAACTGTTTTTGCGACTTTATAGGCAGGTAAATTTTGCTATTACTATTGAATACAAATGACAATTCATT 4481 TATGACCACTCAAACAGCGTTAGTAACCATTTAGTGACAAAGGATTAAAACATCCATCTGGATGTTAATTTTGAAGATGT 4561 AAATTATATGTTGTTTAAATTTTTCCAGGCATCTGAAAACCTTATCTGCTAGACAATGTAAGATTCACACAGAGTTATCT 4641 GGGATTCTGATTTTTTAAATAGTACATATCATTAAACCATTTTCTCTAAATGTAAGAAGAGCAGAAAAAATCTTATAAGA 4721 TTATCAGATTTTTCTAATGACACAGAAATGTAAGAAAAAAATCCCTTTATATTGAAAAAAGATGCAGTCAAAGTCTTTTC 4801 AGACATGCCCAAACTTTGAGAATTTCTTCAACCATCTAATGCTATAAAGATTTTTGTTCTTCCTGTTCACAACCAGTTGT 4881 ATAACAGAAATACTAGCTACTGTTTTCCTTCCTGTGTGTGAAGTAATGAATCATTGATTATGTGACTTGTTATGTATTCA 4961 ATTAAACACTAAAGAATAAAACATTCACTCCTTTAATTATTCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 115207.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 115207.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000377474.2 | 3UTR | CUUGAUUUUCUACUGGGGCCCUUCAAACUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000377474.2 | 3UTR | AUUUUCUACUGGGGCCCUUCAAACUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
133 hsa-miR-3179 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT102087 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT110061 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | ![]() |
![]() |
2 | 6 | ||||||
MIRT112198 | BTG2 | BTG anti-proliferation factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT117668 | SCAMP4 | secretory carrier membrane protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT146657 | MINK1 | misshapen like kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT175505 | ZBTB33 | zinc finger and BTB domain containing 33 | ![]() |
![]() |
2 | 4 | ||||||
MIRT180535 | TXNIP | thioredoxin interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT190624 | BCL2L2-PABPN1 | BCL2L2-PABPN1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT190650 | PABPN1 | poly(A) binding protein nuclear 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT366902 | NONO | non-POU domain containing octamer binding | ![]() |
![]() |
2 | 2 | ||||||
MIRT443554 | ZFP3 | ZFP3 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT445953 | MLLT11 | MLLT11, transcription factor 7 cofactor | ![]() |
![]() |
2 | 2 | ||||||
MIRT446042 | HMCN1 | hemicentin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447968 | MSH6 | mutS homolog 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448634 | ONECUT1 | one cut homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449316 | MRO | maestro | ![]() |
![]() |
2 | 2 | ||||||
MIRT451380 | C19orf43 | telomerase RNA component interacting RNase | ![]() |
![]() |
2 | 2 | ||||||
MIRT451547 | CIAPIN1 | cytokine induced apoptosis inhibitor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451807 | CDCA3 | cell division cycle associated 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT451916 | ILK | integrin linked kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT451938 | TMPRSS5 | transmembrane protease, serine 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452189 | KIAA1456 | KIAA1456 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452498 | HMGXB3 | HMG-box containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452548 | ZNF467 | zinc finger protein 467 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453844 | SDK1 | sidekick cell adhesion molecule 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454515 | ZFYVE27 | zinc finger FYVE-type containing 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455363 | KDM5C | lysine demethylase 5C | ![]() |
![]() |
2 | 2 | ||||||
MIRT455455 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT455628 | PABPC1L2B | poly(A) binding protein cytoplasmic 1 like 2B | ![]() |
![]() |
2 | 10 | ||||||
MIRT455639 | PABPC1L2A | poly(A) binding protein cytoplasmic 1 like 2A | ![]() |
![]() |
2 | 10 | ||||||
MIRT455690 | GLO1 | glyoxalase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT456300 | ASH1L | ASH1 like histone lysine methyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT456784 | MTHFSD | methenyltetrahydrofolate synthetase domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT456819 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | ![]() |
![]() |
2 | 2 | ||||||
MIRT457566 | ZNF34 | zinc finger protein 34 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457604 | IDS | iduronate 2-sulfatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT458236 | NXPH3 | neurexophilin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458313 | TNFAIP8L3 | TNF alpha induced protein 8 like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458350 | NOC2L | NOC2 like nucleolar associated transcriptional repressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT458670 | GPR35 | G protein-coupled receptor 35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459675 | VPS37C | VPS37C, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT461126 | RAB36 | RAB36, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT461918 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462301 | PPM1H | protein phosphatase, Mg2+/Mn2+ dependent 1H | ![]() |
![]() |
2 | 2 | ||||||
MIRT463520 | ZBTB7B | zinc finger and BTB domain containing 7B | ![]() |
![]() |
2 | 2 | ||||||
MIRT464378 | URM1 | ubiquitin related modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464614 | UBE4B | ubiquitination factor E4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT464711 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465520 | PRICKLE4 | prickle planar cell polarity protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465974 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT466058 | TMEM189 | transmembrane protein 189 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466548 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466647 | TAGLN2 | transgelin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467357 | SP2 | Sp2 transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT468744 | SDC2 | syndecan 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT470244 | PRRC2A | proline rich coiled-coil 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT471426 | PDIA6 | protein disulfide isomerase family A member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471732 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472190 | NHP2L1 | small nuclear ribonucleoprotein 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472450 | NAV2 | neuron navigator 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT474563 | KLHDC3 | kelch domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474936 | KCTD15 | potassium channel tetramerization domain containing 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475165 | IP6K1 | inositol hexakisphosphate kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475399 | ICMT | isoprenylcysteine carboxyl methyltransferase | ![]() |
![]() |
2 | 4 | ||||||
MIRT475426 | ICK | intestinal cell kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT477090 | FAM168A | family with sequence similarity 168 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT478458 | DAB2 | DAB2, clathrin adaptor protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT478953 | COX15 | COX15, cytochrome c oxidase assembly homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT480096 | CALR | calreticulin | ![]() |
![]() |
2 | 2 | ||||||
MIRT481924 | ANKRD33B | ankyrin repeat domain 33B | ![]() |
![]() |
2 | 2 | ||||||
MIRT483217 | APOA1 | apolipoprotein A1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT483882 | TGIF1 | TGFB induced factor homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483923 | SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483942 | LENG8 | leukocyte receptor cluster member 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT484209 | SUMO1 | small ubiquitin-like modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484512 | SYT7 | synaptotagmin 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484709 | RNF11 | ring finger protein 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485356 | MYO1C | myosin IC | ![]() |
![]() |
2 | 4 | ||||||
MIRT485615 | FOSL1 | FOS like 1, AP-1 transcription factor subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT486584 | ZNF619 | zinc finger protein 619 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487013 | C2orf82 | chromosome 2 open reading frame 82 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487621 | C20orf96 | chromosome 20 open reading frame 96 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487801 | GPR20 | G protein-coupled receptor 20 | ![]() |
![]() |
2 | 4 | ||||||
MIRT488134 | GPR107 | G protein-coupled receptor 107 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488773 | FXYD1 | FXYD domain containing ion transport regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488854 | UBTF | upstream binding transcription factor, RNA polymerase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT489783 | GRINA | glutamate ionotropic receptor NMDA type subunit associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490102 | FN3K | fructosamine 3 kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT490389 | LHFPL3 | LHFPL tetraspan subfamily member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490434 | MYL9 | myosin light chain 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490451 | GLUD1 | glutamate dehydrogenase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490880 | OSBP | oxysterol binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT491037 | ALPK3 | alpha kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491250 | HCN2 | hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491748 | SEMA3F | semaphorin 3F | ![]() |
![]() |
2 | 2 | ||||||
MIRT492235 | SLC48A1 | solute carrier family 48 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492490 | RAPGEF1 | Rap guanine nucleotide exchange factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492505 | RANBP10 | RAN binding protein 10 | ![]() |
![]() |
2 | 4 | ||||||
MIRT492773 | PDGFB | platelet derived growth factor subunit B | ![]() |
![]() |
2 | 2 | ||||||
MIRT492922 | NFAT5 | nuclear factor of activated T-cells 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493459 | ITFG3 | family with sequence similarity 234 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT493654 | HDLBP | high density lipoprotein binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT494011 | DUSP9 | dual specificity phosphatase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499412 | PLCG2 | phospholipase C gamma 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT499552 | C15orf43 | telomere repeat binding bouquet formation protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501836 | NCOA2 | nuclear receptor coactivator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501950 | MAT2A | methionine adenosyltransferase 2A | ![]() |
![]() |
2 | 10 | ||||||
MIRT504066 | KCTD12 | potassium channel tetramerization domain containing 12 | ![]() |
![]() |
2 | 4 | ||||||
MIRT504509 | PPP1R9B | protein phosphatase 1 regulatory subunit 9B | ![]() |
![]() |
2 | 2 | ||||||
MIRT508466 | HOXB6 | homeobox B6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT512373 | CPM | carboxypeptidase M | ![]() |
![]() |
2 | 2 | ||||||
MIRT513578 | EVX1 | even-skipped homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517763 | ZNF366 | zinc finger protein 366 | ![]() |
![]() |
2 | 4 | ||||||
MIRT519773 | ZNF354B | zinc finger protein 354B | ![]() |
![]() |
2 | 8 | ||||||
MIRT523568 | GGCX | gamma-glutamyl carboxylase | ![]() |
![]() |
2 | 4 | ||||||
MIRT532802 | CLDN11 | claudin 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544299 | TSPYL1 | TSPY like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544862 | MYH2 | myosin heavy chain 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT556731 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 4 | ||||||
MIRT564347 | AKR1B10 | aldo-keto reductase family 1 member B10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568924 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569012 | CXorf36 | chromosome X open reading frame 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569256 | FAM129B | family with sequence similarity 129 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT569591 | PRELP | proline and arginine rich end leucine rich repeat protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT569779 | SAMD14 | sterile alpha motif domain containing 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570034 | FAM228A | family with sequence similarity 228 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT573803 | FRMPD4 | FERM and PDZ domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574190 | ZNF264 | zinc finger protein 264 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576153 | Hmox1 | heme oxygenase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611311 | CA8 | carbonic anhydrase 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT673429 | APAF1 | apoptotic peptidase activating factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674976 | SH3BP2 | SH3 domain binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT692712 | MEAF6 | MYST/Esa1 associated factor 6 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|